MOLINA HEALTHCARE, INC. - COMMON STOCK (MOH)

Historical Holders from Q1 2014 to Q3 2025

Symbol: MOH on NYSE
Type / Class: Equity / COMMON STOCK
Shares outstanding: 53,991,938
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 56,232,696
Holdings value: $10,758,761,896
% of all portfolios: 0.01%
Number of holders: 612
Number of buys: 373
Number of sells: -315
Average buys %: +0.01%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of MOLINA HEALTHCARE, INC. - COMMON STOCK (MOH)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
PRICE T ROWE ASSOCIATES INC /MD/	6.5%	+60%	$671,573,327	+$249,218,079	3,509,476	+59%	T. Rowe Price Associates, Inc.	30 Sep 2025
AQR CAPITAL MANAGEMENT LLC	5.41%		$561,475,117		2,934,130		AQR Capital Management, LLC	30 Sep 2025
Capital Research Global Investors	4%		$645,279,105		2,166,093		Capital Research Global Investors	30 Jun 2025

Institutional Holders of MOLINA HEALTHCARE, INC. - COMMON STOCK (MOH)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	56,232,696	$10,758,761,896	+$329,733,330	$112,710,021	$144,039,794	$191.36	612
2025 Q2	53,143,939	$15,814,934,813	-$59,516,151	$31,873,684	$28,834,807	$297.9	618
2025 Q1	53,318,205	$17,556,102,058	+$91,035,750	$42,289,912	$54,546,718	$329.39	612
2024 Q4	53,180,378	$15,477,621,179	-$852,971,475	$84,913,192	$62,302,242	$291.05	628
2024 Q3	55,753,451	$19,199,929,619	-$928,756,074	$105,027,724	$93,051,886	$344.56	610
2024 Q2	58,617,870	$17,425,900,732	+$502,372,416	$61,310,395	$55,327,530	$297.3	627
2024 Q1	56,839,623	$23,335,901,599	-$303,649,044	$47,204,367	$37,385,530	$410.83	621
2023 Q4	57,640,016	$20,824,881,449	-$191,782,820	$63,216,243	$47,187,086	$361.31	606
2023 Q3	58,035,242	$19,033,464,556	+$26,719,197	$66,791,193	$52,495,189	$327.89	561
2023 Q2	58,046,345	$17,471,402,448	+$426,522,422	$56,332,135	$83,413,356	$301.24	548
2023 Q1	56,729,472	$15,178,264,132	+$33,384,895	$96,608,970	$82,503,327	$267.49	546
2022 Q4	56,448,873	$18,625,852,402	+$134,989,897	$118,548,856	$43,819,774	$330.22	581
2022 Q3	55,952,221	$18,459,660,351	-$700,204,160	$85,430,000	$41,365,000	$329.84	551
2022 Q2	55,992,273	$15,655,695,586	-$92,545,148	$36,841,364	$29,880,244	$279.61	526
2022 Q1	56,374,176	$18,803,260,968	+$567,775,786	$30,839,000	$31,731,000	$333.59	520
2021 Q4	54,698,996	$17,382,776,386	-$297,657,640	$29,807,000	$20,401,000	$318.08	492
2021 Q3	55,513,549	$15,064,016,057	+$42,459,082	$28,288,000	$15,900,000	$271.31	430
2021 Q2	55,433,976	$14,030,996,303	-$50,623,023	$40,916,000	$13,386,000	$253.06	439
2021 Q1	55,652,660	$13,003,593,070	+$32,452,819	$49,295,000	$18,966,000	$233.76	422
2020 Q4	55,362,449	$11,770,646,504	-$359,881,893	$33,603,000	$11,633,000	$212.68	401
2020 Q3	57,178,239	$10,437,229,069	-$222,139,739	$96,507,000	$33,328,000	$183.04	398
2020 Q2	58,643,576	$10,433,524,476	-$428,183,799	$76,539,000	$30,044,000	$177.98	382
2020 Q1	61,041,787	$8,525,814,696	-$434,479,963	$48,502,000	$29,223,000	$139.71	302
2019 Q4	64,018,482	$8,685,900,134	+$494,991,927	$63,782,000	$61,607,000	$135.69	312
2019 Q3	60,660,923	$6,653,658,605	-$49,419,011	$47,379,000	$111,304,000	$109.72	317
2019 Q2	60,840,490	$8,703,029,811	-$217,561,694	$70,396,000	$215,799,000	$143.14	348
2019 Q1	62,947,103	$8,934,940,390	-$384,967,248	$66,779,000	$47,825,000	$141.96	344
2018 Q4	65,790,046	$7,645,679,751	-$202,642,162	$30,607,000	$13,446,000	$116.22	325
2018 Q3	67,173,819	$9,986,021,845	-$614,369,095	$51,004,000	$20,059,000	$148.7	331
2018 Q2	71,841,887	$7,037,065,091	+$143,805,477	$15,187,000	$27,668,000	$97.94	279
2018 Q1	70,629,576	$5,733,843,081	+$630,570,785	$11,258,000	$4,376,000	$81.18	243
2017 Q4	63,342,111	$4,857,698,998	+$245,115,033	$10,613,000	$26,363,000	$76.68	255
2017 Q3	60,388,393	$4,135,781,700	+$335,652,139	$34,036,000	$76,153,000	$68.76	224
2017 Q2	55,496,751	$3,839,489,833	+$191,487,117	$2,897,000	$7,350,000	$69.18	252
2017 Q1	53,439,588	$2,437,065,991	+$230,867,478	$5,601,000	$5,162,000	$45.6	236
2016 Q4	52,138,210	$2,828,569,010	+$41,116,959	$3,386,000	$2,679,000	$54.26	267
2016 Q3	51,271,872	$2,988,235,451	+$89,952,890	$2,766,000	$5,629,000	$58.32	271
2016 Q2	50,125,722	$2,501,756,289	-$2,495,209	$18,044,000	$36,392,000	$49.9	258
2016 Q1	49,184,618	$3,171,610,444	-$93,996,347	$684,000	$3,172,000	$64.49	273
2015 Q4	51,183,454	$3,078,020,154	+$98,104,406	$4,666,000	$2,357,000	$60.13	279
2015 Q3	49,088,384	$3,379,009,154	+$123,091,858	$5,114,000	$13,807,000	$68.85	293
2015 Q2	47,493,817	$3,338,369,536	+$455,102,078	$10,799,000	$6,258,000	$70.3	266
2015 Q1	40,922,320	$2,753,370,094	+$160,526,226	$27,000	$1,479,000	$67.29	229
2014 Q4	38,827,360	$2,078,331,791	+$80,090,293	$0	$132,000	$53.53	194
2014 Q3	37,996,322	$1,607,229,286	+$28,971,330	$523,000	$7,782,000	$42.3	188
2014 Q2	37,122,189	$1,656,318,055	+$102,329,441	$1,557,000	$9,623,000	$44.63	187
2014 Q1	35,129,454	$1,319,227,424	+$12,262,867	$466,000	$8,944,000	$37.56	169